Clinical Trials

Study of Eculizumab in Patients with GMG

ID Number
08-1294

The purpose of this study is to evaluate the safety of the drug eculizumab in a randomized, double-blind, placebo-controlled cross-over trial of patients with generalized Myasthenia Gravis (MG) who have not responded to other MG treatments.